Abstract
Objective
Peripheral microvascular function is altered in preeclampsia (PE). Recent studies suggest that maternal physiology varies with fetal sex. We wanted to examine if there were sex-specific differences in maternal peripheral microvascular function in normal pregnancy and pregnancy complicated by PE.
Methods
Peripheral microvascular responses were examined using the noninvasive technique of laser Doppler flowmetry in normotensive healthy pregnant women and in women diagnosed with PE. We measured baseline perfusion, response to thermal hyperemia, post-occlusive reperfusion, and vasodilatation in response to corticotropin-releasing hormone (CRH), a potent vasodilator in human skin.
Results
At 31 to 40 weeks’ gestation those women with a male fetus exhibited increased vasodilatation in response to CRH (P <0.5) and greater baseline perfusion (P <.05) than those pregnant with a female fetus. PE women pregnant with a male fetus demonstrated a significantly reduced vasodilatation in response to CRH (P <.05), reduced baseline perfusion (P <.05), and reduced response to thermal hyperemia (P <.05) compared to normotensive women pregnant with a male fetus. Microvascular function was not significantly different between preeclamptic and normotensive women with a female fetus.
Conclusion
These data show that there are differences in maternal peripheral microvascular function in relation to fetal sex.
Similar content being viewed by others
References
Abraham WT, Schrier RW. Body fluid volume regulation in health and disease. Adv Intern Med 1994;39:23–47.
Bosio PM, McKenna PJ, Controy R, O’Herlihy C. Matrnal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999;94:978–984.
Alexander BT, Reckelhoff JF, Kassab S, Granger JP. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 1999;33:435–439.
Cox BE, Williams CE, Rosenfeld CR. Angiotensin II indirectly vasoconstricts the ovine uterine circulation. Am J Physiol Regul Integr Comp Physiol 2000;278:R337–R344.
Brooks VL, Clow KA, Welch LS, Giraud GD. Does nitric oxide contribute to the basal vasodilation of pregnancy in conscious rabbits? Am J Physiol Regul Integr Comp Physiol 2001;281:R1624–R1632.
Hibbard J, Shroff SG, Lang RM. Cardiovascular changes in pre-eclampsia. Semin Nephrol 2004;24:580–587.
Eguchi K, Oguni N, Sawai T, Yonezawa M. Comparison of plasma concentrations or arginine vasopressin (AVP) and atrial natriuretic petide (ANP) in normal and pre-eclamptic pregnancies. J Perinat Med 1996;24:437–443.
Salas SP, Rosso P, Espinoza R, Robert JA, Valdes G, Donoso E. Maternal plasma volume expanison and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993;81:1029–1033.
Nadar SK, Karalis I, Yemini E Al, Blann AD, Lip GY. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2005;94:1071–1076.
Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, et al. Expression of the placental cytokines tumour necrosis factor alpha, interleukin-1 beta, and interleukin-10 is increased in pre-eclampsia. Am J Obstet Gynecol 1999;181:915–920.
Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome pre-eclampsia. Am J Hypertens 1991;4:700–708.
Curtis NE, Gude NM, King RG. Nitric oxide metabolites in normal human pregnancy and pre-eclampsia. Hypertens Pregnancy 1995;14:339–349.
Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IMR. Corticotropin releasing hormone causes vasodilatation in human skin via mast cell dependant pathways. J Clin Endocrinol Metab 2003;88:5427–5432.
Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of phsical and behavioural homeostasis. JAMA 1992;267:1244–1252.
Singh LK, Boucher W, Pang X, et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 1999;288:1349–1356.
McLean M, Smith R. Corticotropin-releasing hormone and human parturition. Reproduction 2001;121:493–501.
Clifton VL, Read MA, Leitch IM, et al. corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995;80:2888–2893.
Ingemarsson I. Gender aspects of preterm birth. Br J Obstet Gynaecol 2003;110:34–38.
Cooperstock M, Campbell J. Excess males in preterm birth: Interaction with gestational age, race, and mutiple birth. Obstet Gynaecol 1996;88:189–193.
Stevenson DK, Verter J, Fanaroff AA et al. Sex differences in outcomes of very low birthweight infants: The newborn male disadvantage. Arch Dis Child Fetal Neonat Ed 2000;83:F182–F185.
Clifton VL, Murphy VE. Maternal asthma as a model for examining fetal sex specific effects on maternal physiology and placental mechanisms that regulate human fetal growth. Placenta 2003;168:S45–S42.
Brown MA, Hague WM, Higgins J, et al. Australasian Society of the Study of Hypertension in pregnancy. The detection, investigation, and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol 2000;40:139–155.
Kubli S, Waeber B, Dalle-Ave A, Feihl F. Reproducibility of laser doppler imaging of skin blood flow as a tool to assess endothelial function. J cardiovasc Pharmacol 2000;36:640–648.
Hu J, Norman M, Wallensteen M, Gennser G. Increased large arterial stiffiness and impaired acetlycholine induced skin vasodilatation in women with previous gestational diabetes. Br J Obstet Gynaecol 1998;105:1279–1287.
Tur E, Tamir A, Guy RH. Cutaneous blood flow in gestational hypertension and normal pregnancy. J Invest Dermatol 1992;99:310–314.
Anim-Nyame N, Sooranna SR, Johnson MR, Gamble J, Steer PJ. A longitudenal study of resting periphral blood fow in normal pregnancy and pregnancies complicated by chronic hypertension and pre-eclampsia. Cardiovasc Res 2001;50:603–609.
Beinder E, Schlemabach D. Skin during reactive hyperemia and local hyperthermia in patients with pre-eclampsia. Obstet Gynecol 2001;98:313–318.
Bowyer L, Brown MA, Jones M. Forearm blood flow in preeclampsia. Br J Obstet Gynaecol 2003;110:383–391.
Kisin I, Yuzhakov S. Effects of reserpine, guanethidine, and methyldopa on cardiac output and its distribution. Eur J Pharmacol 1976;35:253–260.
Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics. A crucial adaptation. Obstet Gynecol Sury 2000;55:574–581.
Anumba DO, Robson SC, Boys RJ, Ford GA. Nitric oxide activity in the peripheral vasculature during normotensive and pre-eclamptic pregnancy. Am J Physiol 1999;277:H848–H854.
Parisi VM, Walsh SW. Arachidonic acid metabolites and regulation of placental and other vascular tone during pregnancy. Semin Perinatol 1986;10:288–298.
Kinzler WL, Smulian JC, Ananth CV, Vintzileos AM. Noninvasive ultrasound assessment of maternal vascular reactivity during pregnancy: A longitudinal study. Obstet Gynaecol 2004;104:362–369.
Clifton VL, Crompton R, Smith R, Wright IM. Microvascular effects of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab 2002;87:267–270.
Clifton VL, Read MA, Leitch IM, et al. Corticotropin releasing hormone induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 1994;79:666–669.
Clifton VL, Crompton R, Read MA, Gibson PG, Smith R, Wright IM. Microvascular effects of CRH in human skin vary in relation to oestrogen concentration during the menstrual cycle. J Endocrinology 2005;186:69–76.
Eneroth-Grimfors E, Linblad LE, Westgren M, Ihrman-Sandahl C, Bevegard S. Non-invasive test of microvascular endothelial function in normal and hypertensive pregnancies. Br J Obstet Gynaecol 1993;100:469–471.
Davis KR, Ponnampalam J, Hayman R, Baker PN, Arulkumaran S, Donnelly R. Microvascular vasodilator response to acetlycholine is increased in women with preeclampsia. Br J Obstet Gynaecol 2001;108:610–614.
Kellogg DL, Liu Y, Kosiba IF, O’Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 1999;86:1185–1190.
Beecroft N, Cochrane GM, Milburn HJ. Effect of sex of fetus on asthma during pregnancy: A blind prospective study. BMJ 1998;317:856–857.
Murphy VE, Gibson P, Giles WB, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 2003;168:1317–1323.
Tamimi RM, Mucci LA. Average energy intake among pregnant women carrying a boy compared with a girl. BMJ 2003;326:1245–1246.
Steier JA, Ulstein M, Myking OL. Human chorionic gonadotropin and testosterone in normal and pre-eclamptic pregnancies in relation to fetal sex. Obstet Gynecol 2002;100:552–556.
Al Atawi F, Warsy A, Babay Z, Addar M. Fetal sex and leptin concentration in pregnant females. Ann Saudi Med 2005;25:124–128.
Nelson JL. Microchimerism and human autoimmune diseases. Lupus 2002;11:651–654.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stark, M.J., Dierkx, L., Clifton, V.L. et al. Alterations in the Maternal Peripheral Microvascular Response in Pregnancies Complicated by Preeclampsia and the Impact of Fetal Sex. Reprod. Sci. 13, 573–578 (2006). https://doi.org/10.1016/j.jsgi.2006.06.006
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jsgi.2006.06.006